What are the Newer Applications for Therapeutic Apheresis in Nephrology?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Seminars in dialysis

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/sdi.12525PMID 27461967
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia.

  2016cited by this paper
• Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study

  2015cited by this paper
• A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues

  2015cited by this paper
• Plasma exchange for kidney disease: what is the best evidence?

  2014influential reference
• Syndromes of thrombotic microangiopathy.

  2014influential reference
• Principles of separation: indications and therapeutic targets for plasma exchange.

  2014influential reference
• Long-Term Outcome of Anti-Glomerular Basement Membrane Antibody Disease Treated with Immunoadsorption

  2014cited by this paper
• Guidelines for the management and investigation of hemolytic uremic syndrome

  2014cited by this paper
• Analysis of Protein Removal Properties During Cryofiltration Apheresis Using the Evaflux‐5A Plasma Fractionator in a Patient With Hepatitis C Virus‐Associated Cryoglobulinemic Glomerulonephritis

  2014cited by this paper
• Beneficial effect of LDL-apheresis in refractory nephrotic syndrome

  2014cited by this paper
• Is there clinical value in measuring suPAR levels in FSGS?

  2013influential reference
• Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

  2013influential reference
• KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis.

  2013cited by this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

  2013cited by this paper
• Notice

  2012cited by this paper
• Therapeutic Apheresis Rescue Mission: Recurrent Focal Segmental Glomerulosclerosis in Renal Allografts

  2012cited by this paper
• Obstetric nephrology: preeclampsia--the nephrologist's perspective.

  2012cited by this paper
• KDIGO Clinical Practice Guideline for Glomerulonephritis

  2012cited by this paper
• Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

  2012cited by this paper
• The Role of Therapeutic Apheresis in High Immunologic Risk Renal Transplantation: A Review of Current Trends

  2012influential reference
• Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

  2011influential reference
• Anti-Glomerular Basement Membrane Disease: Outcomes of Different Therapeutic Regimens in a Large Single-Center Chinese Cohort Study

  2011cited by this paper
• Rituximab versus cyclophosphamide for ANCA-associated vasculitis

  2011cited by this paper
• Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial.

  2011influential reference
• Pulmonary-Renal Syndrome with a Focus on Anti-GBM Disease

  2011cited by this paper
• Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

  2010cited by this paper
• Survival and relapse in patients with thrombotic thrombocytopenic purpura.

  2010cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

  2010cited by this paper
• Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

  2010cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients.

  2009cited by this paper
• Atypical hemolytic-uremic syndrome.

  2009cited by this paper
• Sporadic bloody diarrhoea‐associated thrombotic thrombocytopenic purpura‐haemolytic uraemic syndrome: an adult and paediatric comparison

  2008cited by this paper
• EULAR recommendations for the management of primary small and medium vessel vasculitis

  2008cited by this paper
• Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan

  2008cited by this paper
• Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.

  2008cited by this paper
• The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice.

  2007cited by this paper
• Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.

  2007cited by this paper
• Evaluation of Immunosuppressive Regimens in ABO‐Incompatible Living Kidney Transplantation—Single Center Analysis

  2007cited by this paper
• Immunoadsorption in Severe C4d‐Positive Acute Kidney Allograft Rejection: A Randomized Controlled Trial

  2007cited by this paper
• Hemolytic uremic syndrome.

  2005cited by this paper
• Plasma Exchange When Myeloma Presents as Acute Renal Failure

  2005cited by this paper
• Circulating Angiogenic Factors and the Risk of Preeclampsia

  2005cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Successful Rescue Therapy with Plasmapheresis and Intravenous Immunoglobulin for Acute Humoral Renal Transplant Rejection

  2004cited by this paper
• Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.

  2004cited by this paper
• Excellent Long‐term Outcome of ABO‐Incompatible Living Donor Kidney Transplantation in Japan

  2004cited by this paper
• Outcome of severe adult thrombotic microangiopathies in the intensive care unit

  2004cited by this paper
• Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation

  2004cited by this paper
• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

  2003cited by this paper
• ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

  2003cited by this paper
• Apheresis in cryoglobulinemia complicating hepatitis C and in other renal diseases.

  2002cited by this paper
• Risk of renal allograft loss from recurrent glomerulonephritis.

  2002cited by this paper
• Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: Re‐analysis of published case‐reports and case‐series

  2001cited by this paper
• Long-Term Outcome of AntiGlomerular Basement Membrane Antibody Disease Treated with Plasma Exchange and Immunosuppression

  2001cited by this paper
• Glomerulonephritis in mixed cryoglobulinaemia: what treatment?

  1999cited by this paper
• Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution.

  1998cited by this paper
• Cryofiltration apheresis in the United States.

  1998cited by this paper
• Therapeutic plasma exchange in renal diseases.

  1996cited by this paper
• Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis.

  1995cited by this paper
• Severe hypercholesterolemia inhibits cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome.

  1992influential reference
• Comparison of Plasma Exchange With Plasma Infusion in the Treatment of Thrombotic Thrombocytopenia Purpura

  1992cited by this paper
• Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.

  1991cited by this paper
• Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

  1991cited by this paper
• Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4.

  1986cited by this paper
• Therapy of Anti‐Glomerular Basement Membrane Antibody Disease: Analysis of Prognostic Significance of Clinical, Pathologic and Treatment Factors

  1985cited by this paper
• Acute renal failure in essential mixed cryoglobulinemia: precipitation and reversal by plasma exchange.

  1984cited by this paper
• Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis.

  1975cited by this paper
• [Hemolytic-uremic syndrome].

  1973cited by this paper

• No citing papers are available for this paper.